Jason Scott Slakter, Chief Executive Officer at Ohr Pharmaceutical Inc (OHRP), bought 6,250 shares at $3.70 ($23K) on 2016-03-07, disclosed to the SEC on 2016-03-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.41 | 100 | $341 | 1.5% |
| 2 | $3.44 | 100 | $344 | 1.5% |
| 3 | $3.46 | 200 | $692 | 3.1% |
| 4 | $3.49 | 100 | $349 | 1.5% |
| 5 | $3.50 | 100 | $350 | 1.5% |
| 6 | $3.55 | 100 |
| $355 |
| 1.6% |
| 7 | $3.57 | 100 | $357 | 1.6% |
| 8 | $3.58 | 100 | $358 | 1.6% |
| 9 | $3.59 | 100 | $359 | 1.6% |
| 10 | $3.60 | 400 | $1K | 6.4% |
| 11 | $3.61 | 300 | $1K | 4.8% |
| 12 | $3.63 | 2,200 | $8K | 35.2% |
| 13 | $3.64 | 200 | $728 | 3.2% |
| 14 | $3.65 | 300 | $1K | 4.8% |
| 15 | $3.66 | 327 | $1K | 5.3% |
| 16 | $3.70 | 1,523 | $6K | 24.9% |
| Total | $3.63 avg | 6,250 | $23K | 100% |
| Filing → |
| OHRP | BUY | 2016-05-26 | $11K | — | Filing → |
| OHRP | BUY | 2016-05-25 | $89K | — | Filing → |
| OHRP | BUY | 2016-04-12 | $21K | — | Filing → |